About
Immune-based Anticancer Technologies
Reinvent Pharma is a patient-oriented company. The company is developing therapeutics based on a combination of approved drugs designed to improve the clinical outcome of immune and targeted therapies. The company's initial main field of interest is a selected niche of targeted solid tumors such as pancreatic, liver, bile duct, and brain tumors.
Identity
| Name | Reinvent Pharma |
|---|---|
| Slug | reinvent-pharma |
| Former names | Pharmaseed Development |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PC_jqQLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Feb 2026 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | HaMazmera St 9, Ness Ziona, Israel |
Web & social
| https://www.linkedin.com/company/18976543 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
immuno-theraphypharma-companiesdrug-discoverytargeted-therapytherapeuticsoncologypharmaceuticals
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}